Previous reports have described the heterogeneity of different pituitary cell types on the basis of morphological and physiological criteria. In the present study, we investigated the possible existence of distinct subpopulations of melanotrope cells in the intermediate lobe of the pituitary of the frog, Rana ridibunda. Separation of dispersed pars intermedia cells in a Percoll density gradient made it possible to isolate two fractions of melanotrope cells whose morphological and functional properties were further characterized. Analysis of the relative volume and number of various cellular organelles showed that high-density cells had a larger number of secretory granules than low-density cells. Concurrently, radioimmunoassay quantification revealed that the concentration of α-melanocyte-stimulating hormone (α-MSH) was 2 times higher in the heavy cell population. The rate of secretion of α-MSH from cultured melanotrophs was significantly higher in low-density than in high-density cells. Thyrotropin-releasing hormone (TRH) was more potent in stimulating α-MSH release from the low-density than from the high-density cell subset. In contrast, the response to TRH persisted for a longer time in the high-density cell subpopulation. Taken together, these data demonstrate the existence of two subpopulations of melanotrope cells, and indicate that the low-density cells have a secretory rate substantially greater than high-density cells.

Keywords:
Cell heterogeneity, Melanotrope cells, Morphometry, α-Melanocyte-stimulating hormone secretion, Thyrotropin-releasing hormone, Amphibian, Rana ridibunda
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.